Boston Scientific Acquisition Vote Follows Week Of Bad News For Guidant
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific and Guidant shareholders approved the merger of their companies in separate votes March 31, leaving U.S. and European antitrust clearances as the only remaining hurdles to closing the deal